Delving into the Latest Updates on Gifu University of Medical Science with Synapse

Overview

Tags

Nervous System Diseases

Diagnostic radiopharmaceuticals

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Diagnostic radiopharmaceuticals	1
Small molecule drug	1

Top 5 Target	Count

CSF-1R(Colony stimulating factor 1 receptor)	1

Development of an individualized program aimed at maintaining the health of elderly people living alone, ranging from healthy to support level 2 - Focusing on frailty and sarcopenia - - Development of an individualized program aimed at maintaining the health of elderly people living alone, ranging from healthy to support level 2 - Focusing on frailty and sarcopenia -

Start Date22 May 2023

Sponsor / Collaborator

Gifu University of Medical Science

JPRN-UMIN000047578 / Completed

Investigating physical activity of mechanical ventilation patients in the ICU - IPAM study

Start Date01 Sep 2022

Sponsor / Collaborator

Gifu University of Medical Science

JPRN-UMIN000046116 / Completed

Effects of Exercise Instruction Using Sound Stimulation on gait Function and Foot Pressure in Patients with Diabetic Peripheral Neuropathy. - Effect of exercise with sound stimulation on foot pressure in patients with DPN.

Start Date01 Apr 2021

Sponsor / Collaborator

Gifu University of Medical Science

100 Clinical Results associated with Gifu University of Medical Science

Login to view more data

0 Patents (Medical) associated with Gifu University of Medical Science

Login to view more data

395

Literatures (Medical) associated with Gifu University of Medical Science

01 Sep 2024·Journal of Natural Medicines

Correction: Visualizing the spatial distribution of ustalic acid in the fruiting body of Tricholoma kakishimeji

Author: Yamada, Akiyoshi ; Nagai, Hiroyuki ; Fukaya, Masashi ; Ryu, Kaori ; Aoki, Wataru ; Ito, Tetsuro ; Taira, Shu

01 Sep 2024·Journal of Natural Medicines

Visualizing the spatial distribution of ustalic acid in the fruiting body of Tricholoma kakishimeji

Article

Author: Yamada, Akiyoshi ; Nagai, Hiroyuki ; Fukaya, Masashi ; Taira, Syu ; Ryu, Kaori ; Aoki, Wataru ; Ito, Tetsuro

Imaging mass spectrometry (IMS) was conducted for the first time using ustalic acid (UA) and the fruiting body of Tricholoma kakishimeji to localize mushroom toxins. The mushroom materials were systematically collected in Japan, and analysis of the cross sections of the materials at a resolution of 120 μm using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-IMS) revealed the localization of UA and its biogenically related metabolites. MALDI-IMS confirmed that UA was predominantly located on the entire surface of the fruiting body and accumulated in higher amounts in younger fruiting bodies than in mature ones. UA is the first toxic secondary metabolite in the genus Tricholoma locally identified using IMS in mushrooms.

01 Sep 2024·Radiological Physics and Technology

Data analysis of average glandular dose in mammography toward revision of the diagnostic reference level of Japan

Article

Author: Fujise, Daisuke ; Sai, Masahiro ; Shinsho, Kiyomitsu ; Negishi, Toru ; Nishide, Hiroko ; Koba, Yusuke

Diagnostic reference level (DRL) for mammography for 2015 and 2020 has been published by J-RIME. More new dose studies are needed to revise the next DRL. In preparation for the next revision of the DRL for mammography, this study investigated data from the Japan Central Organization on Quality Assurance of Breast Cancer Screening on the mean average glandular dose (AGD) for institutional image accreditation in 2019-2023 and the relationship between the average at eligible institutions to date and the type of breast X-ray system. The 95th percentile values of the AGD distributions for the Computed Radiography (CR) and Flat Panel Detector (FPD) systems were 2.5 mGy and 2.0 mGy, respectively. Moreover, it is assumed that AGD is decreasing due to the spread of FPD systems, and it is expected that the further spread of FPD systems and systems with W/Rh target/filter will reduce AGD in future.

100 Deals associated with Gifu University of Medical Science

Login to view more data

100 Translational Medicine associated with Gifu University of Medical Science

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

Login to view more data